An interventional study of Relaxation Training (RT) and Cognitive Behavioral Therapy Skills Training (CBT) in Advanced Cancer, Metastatic Cancer and Cancer Survivorship, sponsored by H. Lee Moffitt Cancer Center and Research Institute. Not yet recruiting at 2 sites in United States. Open to participants aged 25 Years to 39 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by H. Lee Moffitt Cancer Center and Research Institute · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Neoplasm Metastasis by H. Lee Moffitt Cancer Center and Research Institute — 1 open to participants now, 2 under way, none of them phase 3. Neoplasm Metastasis · H. Lee Moffitt Cancer Center and Research Institute.
Among the 34 studies in Neoplasm Metastasis by H. Lee Moffitt Cancer Center and Research Institute, this one has the largest planned enrollment of the 33 interventional ones that give a count, is the only one that started in 2027, is one of 2 with no phase, and was the 34th registered.
4,045 studies on the registry are indexed under Neoplasm Metastasis; 888 are open to participants now.
Browse Neoplasm Metastasis studies →1 of the 34 studies in Neoplasm Metastasis by H. Lee Moffitt Cancer Center and Research Institute is open now, in 1 country.
By country, each count listing its studies:
Of the 689 Neoplasm Metastasis studies recruiting now, 536 (78%) set no upper age limit and 97 (14%) stop at 75 or younger; 48 take children under 18; 18 take healthy volunteers.
This study: 25 Years to 39 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 17 · Phase 2 17
First in 2005; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 56 is above the median of 50 across 3,270 interventional studies indexed under Neoplasm Metastasis.
Median enrollment 16 across the 33 interventional studies, 10 across the 1 observational. Of the 29 that completed or were terminated, 14 (48%) have results posted.
This tab as a report to print or save as PDF → With an account.
H. Lee Moffitt Cancer Center and Research Institute is the lead sponsor of 541 studies on the registry; 76 are open to participants now.
Of its 99 completed or terminated interventional studies of FDA-regulated products, 57 (58%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 34 studies in Neoplasm Metastasis by H. Lee Moffitt Cancer Center and Research Institute, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this pilot optimization trial is to evaluate the feasibility and acceptability of using an optimization approach to refine DYNAMIC, a behavioral intervention designed to improve psychosocial well-being among young adults ages 25-39 with advanced cancer. This study is guided by the Multiphase Optimization Strategy (MOST) framework. Participants will be randomized using a 2x2x2 factorial design to receive up to three DYNAMIC intervention components: relaxation training (yes/no), cognitive behavioral therapy-based skills training (yes/no), and young-adult relevant health education (yes/no).
Young adults (YAs; ages 25-39) with advanced cancer face substantial psychosocial challenges related to navigating cancer and survivorship during a critical developmental life stage. Despite significant unmet psychosocial support needs, no behavioral interventions have been developed specifically for YAs with advanced cancer. To address this need, our team developed DYNAMIC, a multi-component and evidence-based behavioral intervention designed to improve psychosocial well-being among YAs with advanced cancer. DYNAMIC is delivered to YAs in a group format over videoconference and includes three candidate intervention components: relaxation training (RT), cognitive behavioral therapy-based skills training (CBT), and YA-relevant health education (HE). The goal of this pilot optimization trial is to evaluate the feasibility and acceptability of using an optimization approach to refine DYNAMIC, guided by the Multiphase Optimization Strategy (MOST) framework. In this preparation-phase pilot optimization trial, 56 YAs with advanced cancer will be randomized in groups using a balanced 2x2x2 factorial design. Groups of participants will be assigned to receive or not receive each of three intervention components: RT (yes/no), CBT (yes/no), and HE (yes/no), resulting in eight experimental conditions representing all possible combinations of the candidate intervention components. The primary outcomes are feasibility and acceptability (rates of recruitment, retention, attendance, satisfaction).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Relaxation Training (RT) · Behavioral: Cognitive Behavioral Therapy Skills Training (CBT) · Behavioral: Young Adult-Relevant Health Education (HE)
Behavioral: Relaxation Training (RT) · Behavioral: Cognitive Behavioral Therapy Skills Training (CBT)
Behavioral: Relaxation Training (RT) · Behavioral: Young Adult-Relevant Health Education (HE)
Behavioral: Relaxation Training (RT)
Behavioral: Cognitive Behavioral Therapy Skills Training (CBT) · Behavioral: Young Adult-Relevant Health Education (HE)
Behavioral: Cognitive Behavioral Therapy Skills Training (CBT)
Behavioral: Young Adult-Relevant Health Education (HE)
A relaxation skills program.
A cognitive behavioral skills training program.
A health education program.
Feasibility: Recruitment
The proportion of eligible young adults (ages 25-39) with advanced cancer who enroll in the study among all eligible individuals approached for participation.
Time frame: Baseline
Feasibility: Retention
The proportion of enrolled participants who complete the final follow-up assessment.
Time frame: 6 months
Feasibility: Attendance at the group sessions
The mean number of intervention sessions attended among participants assigned to experimental conditions.
Time frame: 10 weeks
Feasibility: Completion of study assessments
The percentage of scheduled assessments completed, including baseline, post-intervention, and follow-up assessments.
Time frame: 6 Months
Acceptability: Satisfaction with weekly sessions
The mean satisfaction score of individual intervention sessions assessed weekly among participants assigned to experimental conditions using a study-developed satisfaction survey. Responses are scored on a 0-4 Likert scale, with higher scores indicating greater satisfaction.
Time frame: 10 weeks
Acceptability: Satisfaction with overall program
The mean satisfaction score of the overall intervention assessed at post-intervention using a study-developed satisfaction survey. Responses are scored on a 0-4 Likert scale, with higher scores indicating greater satisfaction.
Time frame: Post-intervention, 3 months
Start is estimated for Jan 2027; primary completion for Aug 2028, 19 months later.
Of 291 non-industry interventional studies with no phase under Neoplasm Metastasis, half reached primary completion within 58 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 93. This study's planned 19 months is below that.
Counting every sponsor, half of 316 studies reached it within 54 months; a quarter within 28 and three quarters within 91.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
H. Lee Moffitt Cancer Center and Research Institute →